Christian Angermayer, founder of Presight Capital, invests in early-stage (seed to growth) startups across biotechnology, deep tech. See contact routes.
Christian Angermayer, founder of Presight Capital, invests in early-stage (seed to growth) startups across biotechnology, deep tech, AI/ML, fintech, and controversial frontier sciences like psychedelics and life extension. His distinctive thesis centers on “quality-adjusted life years” (QALYs) and backing transformative, often avoided science such as brain-computer interfaces and psychedelic medicine to extend healthy human lifespan. Notable portfolio companies include ATAI Life Sciences, Compass Pathways, AbCellera, Terran Biosciences, and Left Coast Ventures. Presight Capital can co-lead rounds with check sizes ranging from $500K to over $100M, leveraging its $600M+ AUM to support ambitious founders in undercapitalized global markets.
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Frankfurt when building a target list.
Investors like Christian Angermayer · Full investor directory · Investor access · Company funding database